CD28 and colorectal carcinoma: We found that SH3TC2 was significantly correlated with VTCN1, but not with CTLA4, PDCD1, CD28, or CD70 (Supplementary Figures 2B–2F), implying that SH3TC2 may be involved in CRC immunity through VTCN1.